MedTrace Logo

Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD

NCT00989950 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2012-07-19

Study results available
· View outcomes & findings →

Summary

Methylphenidate may improve sleep in children with ADHD. By leaving Daytrana (methylphenidate) patch for a longer time then 9 hours, many children report short sleep latencies and better quality of sleep.

Conditions

  • Attention Deficit Hyperactivity Disorder
  • INSOMNIA

Interventions

DRUG

Daytrana

Daytrana patch 10-30 mg administered once daily for 9hr

DRUG

Daytrana

Daytrana 10-30 mg worn once daily for 10 hr wear

DRUG

Daytrana

Daytrana 10-30 mg worn once daily for 11 hr

DRUG

Daytrana

Daytrana 10-30 mg worn once daily for 12 hrs

Sponsors & Collaborators

  • Cox Health Systems

    lead OTHER

Principal Investigators

  • arie ashkenasi · pediatric neurology of the ozarks

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00989950 on ClinicalTrials.gov